
Exospas Plus 10mg/325mg Tablet
Marketer
Shankus Acme Pharma Pvt Ltd
Salt Composition
Hyoscine butylbromide (10mg) + Paracetamol (325mg)
Overview Exospas Plus 10mg/325mg Tablet
Combiflex Relief 10mg/325mg tablets offer dual-action relief from abdominal discomfort. This formulation eases abdominal pain and cramping by relaxing the gastrointestinal muscles and inhibiting pain and fever-inducing neurotransmitters. Combiflex Relief should be taken as directed by your physician, with or without food, for the prescribed duration. Dosage is individualized based on your response and condition; premature discontinuation may lead to symptom recurrence and potential worsening. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include constipation, dry mouth, blurred vision, and tachycardia; these are often transient and self-limiting. Report any concerning side effects immediately. Prior to commencing treatment, disclose any pregnancy, pregnancy plans, breastfeeding, or kidney/liver conditions to ensure appropriate dosage adjustment.
Primary Ingredients of Exospas Plus 10mg/325mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Exospas Plus 10mg/325mg Tablet
Stomach spasm
Major Benefits of Exospas Plus 10mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Exospas Plus 10mg/325mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consumption may coincide with meals or not, but consistency in timing is recommended.
Common Side effects of Exospas Plus 10mg/325mg Tablet:
- Constipation
- Dryness in mouth
- Blurred vision
- Slow heart rate
How to use Exospas Plus 10mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Exospas Plus 10mg/325mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. These tablets can be administered with or without food, although consistent timing is recommended.
How Exospas Plus 10mg/325mg Tablet works:
Each Exospas Plus 10mg/325mg tablet combines hyoscine butylbromide and paracetamol to alleviate abdominal pain and cramping. The anticholinergic hyoscine butylbromide eases stomach and intestinal muscle contractions, thus reducing spasms, pain, bloating, and discomfort. Paracetamol, an analgesic, provides pain relief by inhibiting the production of pain-signaling chemicals.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Exospas Plus 10mg/325mg Tablets should not be taken together.
PregnancyCONSULT YOUR DOCTOR
The use of Exospas Plus 10mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Exospas Plus 10mg/325mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Exospas Plus 10mg/325mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Exospas Plus 10mg/325mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Exospas Plus 10mg/325mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Exospas Plus 10mg/325mg tablets are contraindicated in patients with severe or active liver disease.
What if you forget to take Exospas Plus 10mg/325mg Tablet :
Should you forget a dose of Exospas Plus 10mg/325mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Exospas Plus 10mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
